Geode Capital Management’s IGC Pharma IGC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $215K | Buy |
703,303
+3,289
| +0.5% | +$1.01K | ﹤0.01% | 3848 |
|
|
2025
Q1 | $200K | Buy |
700,014
+30,329
| +5% | +$8.65K | ﹤0.01% | 3851 |
|
|
2024
Q4 | $225K | Buy |
669,685
+106,716
| +19% | +$35.9K | ﹤0.01% | 3868 |
|
|
2024
Q3 | $240K | Buy |
562,969
+133,142
| +31% | +$56.8K | ﹤0.01% | 3849 |
|
|
2024
Q2 | $187K | Buy |
429,827
+105,531
| +33% | +$45.8K | ﹤0.01% | 3937 |
|
|
2024
Q1 | $130K | Hold |
324,296
| – | – | ﹤0.01% | 4075 |
|
|
2023
Q4 | $90.9K | Hold |
324,296
| – | – | ﹤0.01% | 4216 |
|
|
2023
Q3 | $117K | Buy |
324,296
+22,156
| +7% | +$7.96K | ﹤0.01% | 4192 |
|
|
2023
Q2 | $94.1K | Hold |
302,140
| – | – | ﹤0.01% | 4356 |
|
|
2023
Q1 | $103K | Hold |
302,140
| – | – | ﹤0.01% | 4329 |
|
|
2022
Q4 | $96K | Sell |
302,140
-744
| -0.2% | -$236 | ﹤0.01% | 4415 |
|
|
2022
Q3 | $130K | Hold |
302,884
| – | – | ﹤0.01% | 4437 |
|
|
2022
Q2 | $160K | Buy |
302,884
+10,395
| +4% | +$5.49K | ﹤0.01% | 4386 |
|
|
2022
Q1 | $277K | Hold |
292,489
| – | – | ﹤0.01% | 4216 |
|
|
2021
Q4 | $285K | Hold |
292,489
| – | – | ﹤0.01% | 4315 |
|
|
2021
Q3 | $432K | Buy |
292,489
+20,484
| +8% | +$30.3K | ﹤0.01% | 4100 |
|
|
2021
Q2 | $446K | Buy |
272,005
+10,334
| +4% | +$16.9K | ﹤0.01% | 3994 |
|
|
2021
Q1 | $468K | Hold |
261,671
| – | – | ﹤0.01% | 3837 |
|
|
2020
Q4 | $408K | Hold |
261,671
| – | – | ﹤0.01% | 3653 |
|
|
2020
Q3 | $272K | Hold |
261,671
| – | – | ﹤0.01% | 3623 |
|
|
2020
Q2 | $156K | Hold |
261,671
| – | – | ﹤0.01% | 3731 |
|
|
2020
Q1 | $128K | Hold |
261,671
| – | – | ﹤0.01% | 3680 |
|
|
2019
Q4 | $164K | Buy |
261,671
+2,886
| +1% | +$1.81K | ﹤0.01% | 3863 |
|
|
2019
Q3 | $251K | Buy |
258,785
+60,177
| +30% | +$58.4K | ﹤0.01% | 3697 |
|
|
2019
Q2 | $325K | Buy |
+198,608
| New | +$325K | ﹤0.01% | 3623 |
|